Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL27968185 | 0.95 | CA2 (0.39) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL27543121 | 0.95 | CA2 (0.39) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL1895697 | 0.95 | CA2 (0.39) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL23272305 | 0.95 | CA2 (0.39) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL28985930 | 0.91 | CA2 (0.36) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL28551343 | 0.91 | CA2 (0.36) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL22396378 | 0.91 | CA2 (0.36) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL4449347 | 0.91 | CA2 (0.36) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL28232845 | 0.91 | CA2 (0.36) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL28223187 | 0.91 | CA2 (0.36) | CA2SLC34A1KDM4EMMP2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734939-A2 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACIDS | The Procter & Gamble Company (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4734922-A2 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACIDS AND TIN | The Procter & Gamble Company (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260102322-A1 | ORAL CARE COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | PROCTER & GAMBLE (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260083649-A1 | ORAL CARE COMPOSITIONS COMPRISING MINT OIL AND TIN | PROCTER & GAMBLE (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260076894-A1 | ORAL CARE COMPOSITIONS COMPRISING HOPS AND TIN | PROCTER & GAMBLE (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4312981-B1 | EDIBLE ORAL COMPOSITIONS COMPRISING HOPS | PROCTER & GAMBLE (US) | 2025-11-05 | — | — | EP | disclosed |
| EP-4640205-A2 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND FLUORIDE | The Procter & Gamble Company (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250295565-A1 | Oral Care Compositions Comprising Hops Beta Acids And Fluoride Ions | PROCTER & GAMBLE (US) | 2025-09-25 | — | — | US | disclosed |
| EP-4037765-B1 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO ACID | PROCTER & GAMBLE (US) | 2025-08-20 | — | — | EP | disclosed |
| US-12350355-B2 | Oral care compositions comprising hops beta acids and fluoride ions | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | disclosed |
| WO-2021063378-A1 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO ACID | THE PROCTER & GAMBLE COMPANY (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2021067992-A1 | METHODS OF USE OF ORAL CARE COMPOSITIONS COMPRISING HOPS | THE PROCTER & GAMBLE COMPANY (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2021067994-A1 | FLUORIDE-FREE ANTICAVITY ORAL CARE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2021067995-A1 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND METAL ION | THE PROCTER & GAMBLE COMPANY (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2021067993-A1 | ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND FLUORIDE | THE PROCTER & GAMBLE COMPANY (US) | 2021-04-08 | — | — | WO | disclosed |
| US-20210093551-A1 | Methods Of Use Of Oral Care Compositions Comprising Hops | THE PROCTER & GAMBLE COMPANY | 2021-04-01 | — | — | US | disclosed |
| US-20210093549-A1 | Fluoride-Free Anticavity Oral Care Compositions | THE PROCTER & GAMBLE COMPANY | 2021-04-01 | — | — | US | disclosed |
| US-20210093550-A1 | Oral Care Compositions Comprising Hops Beta Acids And Metal Ions | THE PROCTER & GAMBLE COMPANY | 2021-04-01 | — | — | US | disclosed |
| US-20210093528-A1 | Oral Care Compositions With Anticaries Activity | THE PROCTER & GAMBLE COMPANY | 2021-04-01 | — | — | US | disclosed |
| US-20210093525-A1 | Oral Care Compositions Comprising Hops Beta Acids And Fluoride Ions | THE PROCTER & GAMBLE COMPANY | 2021-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083649-A1 | ORAL CARE COMPOSITIONS COMPRISING MINT OIL AND TIN | TAS2R40, SOD1, TAS2R10 | CA2 1093/4885SLC34A1 2099/4885KDM4E 3518/4885 |
| US-20210093525-A1 | Oral Care Compositions Comprising Hops Beta Acids And Fluoride Ions | HAX1, AFF1, FGF1 | CA2 282/4885SLC34A1 1591/4885KDM4E 4697/4885 |
| US-20250295565-A1 | Oral Care Compositions Comprising Hops Beta Acids And Fluoride Ions | HAX1, AP3S1, AFF1 | CA2 305/4885SLC34A1 1612/4885KDM4E 4723/4885 |
| US-20260102322-A1 | ORAL CARE COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | OTC, ODC1, SDC1 | CA2 227/4885SLC34A1 52/4885KDM4E 3762/4885 |
| US-20260076894-A1 | ORAL CARE COMPOSITIONS COMPRISING HOPS AND TIN | SOD1, SOD3, HMBS | CA2 980/4885SLC34A1 1281/4885KDM4E 4050/4885 |
| US-20210093549-A1 | Fluoride-Free Anticavity Oral Care Compositions | HAX1, AFF1, F7 | CA2 508/4885SLC34A1 3103/4885KDM4E 4511/4885 |
| US-20210093550-A1 | Oral Care Compositions Comprising Hops Beta Acids And Metal Ions | HMBS, NIPSNAP1, SLC39A11 | CA2 809/4885SLC34A1 646/4885KDM4E 4845/4885 |
| US-20210093551-A1 | Methods Of Use Of Oral Care Compositions Comprising Hops | POLR1C, CFL1, HYPK | CA2 424/4885SLC34A1 3565/4885KDM4E 4343/4885 |
| US-20210093528-A1 | Oral Care Compositions With Anticaries Activity | NAF1, GALC, GANC | CA2 47/4885SLC34A1 2972/4885KDM4E 3439/4885 |
| US-12350355-B2 | Oral care compositions comprising hops beta acids and fluoride ions | HAX1, AP3S1, AFF1 | CA2 305/4885SLC34A1 1612/4885KDM4E 4723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.